Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Operating Income: 2024-2025

Historic Operating Income for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to -$80.0 million.

  • Kura Oncology's Operating Income fell 33.59% to -$80.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$239.8 million, marking a year-over-year change of. This contributed to the annual value of -$193.2 million for FY2024, which is 16.52% down from last year.
  • Per Kura Oncology's latest filing, its Operating Income stood at -$80.0 million for Q3 2025, which was down 10.09% from -$72.7 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Operating Income ranged from a high of -$22.5 million in Q4 2024 and a low of -$80.0 million during Q3 2025.
  • Over the past 2 years, Kura Oncology's median Operating Income value was -$59.9 million (recorded in 2024), while the average stood at -$58.7 million.
  • Data for Kura Oncology's Operating Income shows a maximum YoY tumbled of 33.59% (in 2025) over the last 5 years.
  • Over the past 2 years, Kura Oncology's Operating Income (Quarterly) stood at -$22.5 million in 2024, then tumbled by 33.59% to -$80.0 million in 2025.
  • Its Operating Income was -$80.0 million in Q3 2025, compared to -$72.7 million in Q2 2025 and -$64.7 million in Q1 2025.